Predictive accuracy of machine learning models for conservative treatment failure in thoracolumbar burst fractures

机器学习模型对胸腰椎爆裂性骨折保守治疗失败的预测准确性

阅读:1

Abstract

BACKGROUND: The management of patients with thoracolumbar burst fractures remains a topic of debate, with conservative treatment being successful in most cases but not all. This study aimed to assess the utility of machine learning models (MLMs) in predicting the need for surgery in patients with these fractures who do not respond to conservative management. METHODS: A retrospective analysis of 357 patients with traumatic thoracolumbar burst fractures treated conservatively between January 2017 and October 2023 was conducted. Various potential risk factors for treatment failure were evaluated, including age, gender, BMI, smoking, diabetes, vertebral body compression rate, anterior height compression, Cobb angle, interpedicular distance, canal compromise, and pain intensity. Three MLMs-random forest (RF), support vector machine (SVM), and k-nearest neighborhood (k-NN)-were used to predict treatment failure, with the RF model also identifying factors associated with treatment failure. RESULTS: Among the patients studied, most (85.2%) completed conservative treatment, while 14.8% required surgery during follow-up. Smoking (OR: 2.01; 95% CI: 1.54-2.86; p = 0.011) and interpedicular distance (OR: 2.31; 95% CI: 1.22-2.73; p = 0.003) were found to be independent risk factors for treatment failure. The MLMs demonstrated good performance, with SVM achieving the highest accuracy (0.931), followed by RF (0.911) and k-NN (0.896). SVM also exhibited superior sensitivity and specificity compared to the other models, with AUC values of 0.897, 0.854, and 0.815 for SVM, RF, and k-NN, respectively. CONCLUSION: This study underscores the effectiveness of MLMs in predicting conservative treatment failure in patients with thoracolumbar burst fractures. These models offer valuable prognostic insights that can aid in optimizing patient management and clinical outcomes in this specific patient population.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。